Joseph S Zakrzewski An2 Therapeutics, Inc. (ANTX) insider trading activity

Joseph S Zakrzewski is of AN2 Therapeutics, Inc.. Currently has a direct ownership of 145,538 shares of ANTX, which is worth approximately $183,377. The most recent transaction as insider was on Apr 10, 2025, when has been sold 10,523 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 146K

7.79% 3M change

48.21% 12M change

Total Value Held $183,377

Joseph S Zakrzewski Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 10 2025	BUY Grant, award, or other acquisition	-	10,523 Added 6.74%	145,538 Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	9,816 Added 6.78%	135,015 Common Stock
Nov 27 2024	BUY Open market or private purchase	$2,800 $1.4 p/Share	2,000 Added 1.57%	125,199 Common Stock
Nov 19 2024	BUY Open market or private purchase	$5,050 $1.01 p/Share	5,000 Added 3.9%	123,199 Common Stock
Nov 18 2024	BUY Open market or private purchase	$20,000 $1.0 p/Share	20,000 Added 14.47%	118,199 Common Stock
Mar 29 2022	BUY Conversion of derivative security	-	98,199 Added 50.0%	98,199 Common Stock

Also insider at

AMRN

AMARIN CORP PLCUK Healthcare

XLRN

ACCELERON PHARMA INC Healthcare

Director

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

Director

CYT

Cyteir Therapeutics, Inc. Healthcare

Director

JSZ